Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback